New Grants Are Pushing Psychedelic Therapy Into End of Life Care
Seven organizations across the country received a combined $566,260 to advance research and training in this emerging field.
Read More
A Psychedelic That Mimics Meditation? New Research Says Yes
A powerful psychedelic may produce the same brain state as decades of meditation practice.
Read More
Low Dose Psilocybin Shows Metabolic Benefits Without the Trip
Psilocybin may do more than reshape how we think. New research suggests it could reshape how our bodies process fat, sugar, and insulin.
Read More
Washington State Senators Advance Bill to Legalize Psilocybin Therapy
Washington State took a significant step toward creating a regulated framework for therapeutic psilocybin use this week.
Read More
New Study Reveals Why Ketamine Therapy Works — And It Starts With Your Patient’s Metabolism
Without the metabolite 2R6R, ketamine alone failed to produce the lasting brain plasticity tied to its therapeutic effects.
Read More
Colorado Poised to Become First State to Offer Regulated Ibogaine Therapy
Colorado regulators are reviewing rules that could add ibogaine to the state's Natural Medicine program -- making it the first to do so.
Read More
2026 Could Be the Year Psychedelics Finally Break Through
Psychedelic medicine is entering its most consequential year yet as two companies are preparing to file for FDA approval of treatments.
Read More
Psilocybin Shows Promise for Long COVID Symptoms in New Study
Millions of people continue to struggle with long COVID. Now, new research suggests psilocybin mushrooms may offer relief.
Read More
Attorney General Misses Deadline to Streamline Research on Psychedelics
The Department of Justice failed to meet a January 16 deadline to publish new rules simplifying Schedule I research.
Read More
Psilocybin Microdoses Boost Creative Quality, Not Quantity, Study Finds
Researchers found that small doses of psilocybin can improve the originality, but not the amount, of creative ideas.
Read More